| CTRI Number |
CTRI/2018/11/016288 [Registered on: 08/11/2018] Trial Registered Prospectively |
| Last Modified On: |
27/04/2023 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [N/AP] |
| Study Design |
Other |
|
Public Title of Study
|
Safety assessment of products on skin |
|
Scientific Title of Study
|
Evaluation of irritation potential of Skin Care Formulations on healthy human subjects. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| D01-6Q13-TE-OR18; Version: 01; Dated: 23/10/2018 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Raji Patil |
| Designation |
Investigator |
| Affiliation |
Mascot Spincontrol India Pvt. Ltd. |
| Address |
Mascot Spincontrol India Pvt. Ltd.
Unit 2, Neeru Silk Mills,
Mathuradas Mill compound,
N.M. Joshi Marg - Lower Parel,
Mumbai – 400013, INDIA
Mumbai (Suburban)
MAHARASHTRA
400013
India |
| Phone |
022-43349191 |
| Fax |
|
| Email |
raji@mascotspincontrol.in |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Raji Patil |
| Designation |
Investigator |
| Affiliation |
Mascot Spincontrol India Pvt. Ltd. |
| Address |
Mascot Spincontrol India Pvt. Ltd.
Unit 2, Neeru Silk Mills,
Mathuradas Mill compound,
N.M. Joshi Marg - Lower Parel,
Mumbai – 400013, INDIA
Mumbai (Suburban)
MAHARASHTRA
400013
India |
| Phone |
022-43349191 |
| Fax |
|
| Email |
raji@mascotspincontrol.in |
|
Details of Contact Person
Public Query
|
| Name |
Mr Mohit Lalvani |
| Designation |
Study Director |
| Affiliation |
Mascot Spincontrol India Pvt. Ltd. |
| Address |
Mascot Spincontrol India Pvt. Ltd.
Unit 2, Neeru Silk Mills,
Mathuradas Mill compound,
N.M. Joshi Marg - Lower Parel,
Mumbai – 400013, INDIA
Mumbai (Suburban)
MAHARASHTRA
400013
India |
| Phone |
022-43349191 |
| Fax |
|
| Email |
mohit@mascotspincontrol.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
TTK Healthcare Limited |
| Address |
Protective Devices Division,
Research and Development No. 3,
Thirunerrmalai Road, Chrompet, Chennai-600044, Tamil Nadu, India |
| Type of Sponsor |
Other [FMCG] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Raji Patil |
Mascot-Spincontrol India Pvt. Ltd. |
Unit 2, Neeru Silk Mills,
Mathuradas Mill compound,
N.M. Joshi Marg - Lower Parel,
Mumbai – 400013, INDIA
Mumbai (Suburban)
MAHARASHTRA |
022-43349191
raji@mascotspincontrol.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethos- An Institutional Ethics committee (Mumbai) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Not Applicable |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Deodorant
Brand Name: SKORE(SD-002)
Deodorant
Brand Name: SKORE(SD-006)
Deodorant
Brand Name: SKORE(SD-007)
Deodorant
Brand Name: SKORE(SD-008)
Deodorant
Brand Name: SKORE(SD-009)
Pocket Perfume
Brand Name: SKORE(SPP-001)
Pocket Perfume
Brand Name: SKORE(SPP-002)
Orgasmic Gel
Brand Name: SKORE OH! (SOG-17) |
1. For Products 1 to 7, the products are aerosol product. So it is applied by semi-occlusive method. The product is dispensed directly on the skin on the back of volunteer and it is occluded by the patch after it gets evaporated at T0 visit.
2. For product 8, The product are directly dispensed in the aluminium finn chambers of the patch and applied on the back of the volunteers at T0 visit |
| Comparator Agent |
Sodium Lauryl Sulphate (SLS) 3% Solution
Negative Control (Distilled Water) |
Not Applicable |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
Subjects willing to come for regular follow up and ready to follow instructions during the study period |
|
| ExclusionCriteria |
| Details |
For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the irritation potential on healthy human subjects of Skin Care Formulations. |
T0 (Evaluation of test sites by Dermatologist and Subject,
Patch application)
T1(Patch removal, Evaluation of test sites by Dermatologist, T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal)
T8 (Evaluation of test sites by Dermatologist and Subject post 1 week of patch removal and tracking the positive cases).
Formulations. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Not Applicable |
Not Applicable |
|
|
Target Sample Size
|
Total Sample Size="24"
Sample Size from India="24"
Final Enrollment numbers achieved (Total)= "24"
Final Enrollment numbers achieved (India)="24" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
08/11/2018 |
| Date of Study Completion (India) |
22/11/2018 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0"
Months="0"
Days="8" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
Not Applicable |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Single Application, semi occlusive, Closed Patch Test is conducted to measure the irritation potential of cosmetic products on the skin. Objective: To evaluate the irritation potential on healthy human subjects of Skin Care Formulations. Duration of study: 8 days study Kinetics: T0 (Evaluation of test sites by Dermat and Subject, Patch application) T1(Patch removal, Evaluation of test sites by Dermat T2(Evaluation of test sites by Dermat and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases) Population 24 healthy subjects(12 males + 12 females) Products : Deodorant Brand Name: SKORE(SD-002), Deodorant Brand Name: SKORE(SD-006), Deodorant Brand Name: SKORE(SD-007), Deodorant Brand Name: SKORE(SD-008), Deodorant Brand Name: SKORE(SD-009), Pocket Perfume Brand Name: SKORE(SPP-001), Pocket Perfume Brand Name: SKORE(SPP-002), Orgasmic Gel Brand Name: SKORE OH! (SOG-17) Positive control : 3% SLS Negative Control :Distilled Water The test area is checked for erythema and oedema caused due to the products and compared with positive control. |